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http:WHAT THIS PAPER ADDS
By analyzing the characteristics of the false lumen in open operated cases, this article reconsiders the usefulness
of open surgery for chronic dissection, and shows improving operative results.Objective/background: Recently, the indications for thoracic endovascular aortic repair (TEVAR) have been
expanding, and the applicability of TEVAR for acute type B aortic dissection (TBAD) is proposed with regard to the
high mortality of open surgery for chronic TBAD. TEVAR in the acute phase may lead to remodeling of the false
lumen (FL), but it is controversial whether it completely resolves the aortic expansion in the chronic phase. In this
study, operative results and the relationship between FL status and the time before surgical intervention were
retrospectively analyzed.
Methods: From January 2008 to September 2013, 234 patients underwent open surgery for chronic TBAD. Most
patients were on left heart bypass. By considering Japanese aortic disease treatment guidelines and the smaller
physique of Japanese patients, operative indications were aneurysm >50 mm in diameter or rapid aneurysm
enlargement of >5 mm in a 6 month period.
Results: In 180 cases, the FL was patent. The mean interval between onset of TBAD and operation was 61  54
months. There was no signiﬁcant difference between patients in the patent FL group and those in the
thrombosed FL group (p ¼ .44). Mean ratio of FL diameter to maximum aortic diameter (FL/AD) was 0.64  0.21.
There was no correlation between FL and AD before the operation (r ¼ .12). Descending thoracic aortic
replacement (DTAR) was performed in 127 cases and thoracic ascending aortic replacement (TAAR) in 107 cases
(Crawford type I, n ¼ 9; Crawford type II, n ¼ 65; Crawford type III and IV, n ¼ 22, respectively; Saﬁ type V,
n ¼ 11). The overall operative mortality was 6.8%: 3.9% (5/127) for DTAR and 10.3% (11/107) for TAAR. The three
year survival was 86.7, and the freedom from re-intervention rate was 97.0%.
Conclusion: Enlargement of uncomplicated TBAD in the chronic phase was poorly related to FL status and the
results of open repair have improved. However, further prospective study is necessary.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Recent advances in thoracic endovascular aortic repair
(TEVAR) have led to an expansion of indications for surgery
for acute type B aortic dissection (TBAD). Multiple studies
have found that for complicated acute cases of TBAD
accompanied by organ malperfusion, TEVAR is associated
with favorable outcomes.1,2 The usefulness of TEVAR for
uncomplicated acute TBAD has also been reported withof original article: http://dx.doi.org/10.1016/j.ejvs.2015.08.011
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//dx.doi.org/10.1016/j.ejvs.2015.07.012high mortality and morbidity of open surgery for expanded
chronic TBAD. TEVAR in the acute phase may lead to
remodeling of false aortic lumen (FL), that is, progressive
reduction in diameter, and thrombosis of the FL. It does not
mean that TEVAR in the acute phase completely resolves
the aortic expansion in the chronic phase.
Open surgery for chronic TBAD is associated with rela-
tively high mortality and morbidity rates,3 and the impor-
tance of early intervention for uncomplicated TBAD has
been emphasized by some studies.4,5 However optimized
medical treatment with antihypertensive agents and rest
has a long history and is still the gold standard.6
At the authors’ institution, the basic strategy for
uncomplicated TBAD is conservative treatment in the acute
phase and open surgery in the chronic phase if patients
Chronic Stanford Type B Aortic Dissection 739present with aneurysmal changes, and operative results
have improved.
The objective of current study was to clarify whether FL
status (diameter and thrombosis) has any relationship with
the duration of critical expansion, and to examine whether
open surgery in the chronic phase is a valid treatment
option.MATERIALS AND METHODS
Patient population
Between January 2008 and September 2013, 621 patients
underwent descending thoracic and thoraco-abdominal
aortic replacement (DTAR and TAAR, respectively). Of
these patients, 234 had chronic Stanford type B aortic dis-
sections. At the authors’ institution, patients meeting the
indication for surgery are allowed to opt for it. For this
reason, patients were rarely refused surgery. In the same
period, only 49 cases of TEVAR were preformed; one case
was for acute TBAD, and two cases were for chronic TBAD.
The indication for DTAR or TAAR was an overall aortic
diameter of >50 mm, rapid enlargement of >5 mm within
6 months, infection, or rupture. This is based on Japanese
aortic disease treatment guidelines, which recommend
surgery for rapidly enlarging aneurysms that dilate >5 mm
in 6 months, and the authors’ experience that 90% of
ruptured or impending ruptured descending thoracic and
thoraco-abdominal aneurysms were >50 mm. Prior to
surgery, patients underwent computed tomography (CT)
annually until the maximum aortic diameter exceeded
50 mm. After surgery, CT was performed at 3, 6, and 12
months and annually thereafter.
The pre-operative characteristics of the patients are
described in Table 1. Pre-operative FL status was assessed
by pre-operative enhanced CT. Patent FL was deﬁned as theTable 1. Pre-operative characteristics.
All patients
(n ¼ 234)
DTA
(n ¼ 127)
TAAA
(n ¼ 107)
p
Mean  SD
age (y)
60.4  13.0 60.5 59.5 .57
Male 187 (79.9) 108 (85.0) 79 (73.8) .03
Coronary arterial
disease
45 (19.2) 23 (18.1) 18 (16.8) .53
Chronic lung
disease
46 (19.7) 32 (25.2) 14 (13.1) .02
Smoking 126 (53.8) 74 (58.3) 52 (48.6) .16
Diabetes 16 (6.8) 11 (8.7) 5 (4.7) .22
Chronic renal
insufﬁciency
16 (6.8) 7 (5.5) 9 (8.4) .38
Hemodialysis 10 (4.3) 4 (3.1) 6 (5.6) .35
Emergent or urgent
operation
18 (7.7) 8 (6.3) 10 (9.3) .38
Mean  SD maximum
diameter (mm)
58.4  10.7 57.5 59.6 .14
Note. Data are n (%) unless otherwise indicated.
DTA ¼ Descending thoracic aneurysm; TAAA ¼ Thoraco-
abdominal aortic aneurysm.absence of thrombi in the FL. FL thrombosis was deﬁned as
the absence of contrast in the FL on CT, and partial lumen
thrombosis was deﬁned as the presence of both thrombosis
and contrast in the FL. FL patency was assessed by venous
phase CT angiography if possible. In three cases, enhanced
CT scans were not performed.
To calculate the FL/aortic diameter (AD) ratio, the largest
axial aortic diameter image was used. True lumen and FL
were determined by evaluating continuity with the normal
aorta lumen.
Study variables
Regarding the pre-operative variables, chronic renal failure
as the indication for dialysis and chronic renal insufﬁciency
were deﬁned as a serum creatinine level >2.0 mg/dL.
All operations were performed >30 days after the onset
of aortic dissection, based on Japanese guidelines
(Guidelines for Diagnosis and Treatment of Aortic Aneu-
rysm and Aortic Dissection) that deﬁne the period within 2
weeks as the acute phase, and the period after the acute
phase as the chronic phase. The maximum aortic diameter
was based on measurements of all segments of the
descending thoracic, thoraco-abdominal and abdominal
aorta, and the largest diameter was used as the maximum
diameter.
Operative death was deﬁned as death within 30 days of
surgery. Post-operative acute renal dysfunction was deﬁned
as the need for temporary dialysis during the post-operative
period. Spinal cord deﬁcits were deﬁned as deﬁcits present
at discharge and were further classiﬁed according to
severity as follows: permanent paraplegia (unable to move
legs) and paraparesis (partial paralysis of the lower limbs).
Pulmonary complications included atelectasis necessitating
non-invasive positive pressure ventilation; pleural effusion
requiring drainage; pneumonia; pneumothorax; prolonged
ventilation (>48 h); chylothorax; and tracheostomy. When
the incidence of complications was calculated, multiple
events (e.g., atelectasis and tracheostomy) within the same
category were treated as a single occurrence.
To better assess the overall incidence of major compli-
cations, major adverse outcomes were deﬁned as: in hos-
pital death (including operative death), spinal cord
ischaemia, severe stroke, the need for de novo dialysis at
discharge, and tracheostomy.
Operative procedure
The basic strategy was left heart bypass (LHB). The LHB
circuit included an in line centrifugal pump with a heat
exchanger. For this purpose, cannulae were placed in the
left atrium for outﬂow and the left common femoral artery
for inﬂow. Spinal drainage was not performed pre-
operatively in descending thoracic aortic aneurysm and
Saﬁ type V aneurysm repair. In Crawford type I, II, III, and IV
aneurysm repairs, spinal drainage was normally performed
pre-operatively. Spinal drainage was removed 3 days after
surgery. Post-operatively, systolic blood pressure was
maintained between 140 mmHg and 160 mmHg. Intra-
740 T. Fujikawa et al.operative neurological measurements such as motor-
evoked potential were not used.Table 2. Operative data (n ¼ 234).
Operative characteristic n (%)
Previous aortic operation 138 (43.7)
Abdominal aorta 24 (7.6)
Thoracic aorta 122 (38.6)
Aortic replacement
Descending thoracic aorta 127 (54.3)
Thoraco-abdominal aorta 107 (45.7)
Crawford extent I 9 (3.8)
Crawford extent II 65 (27.8)
Re-implanted intercostal arteries 74 (31.6)
Re-implanted visceral arteries 84 (35.9)
Bevelled 14 (6.0)
Perfusion strategy
Left heart bypass 223 (95.3)
Deep hypothermia and circulatory arrest 6 (2.6)
Others 5 (2.1)Statistical analysis
Data are presented as n (%) for discrete variables and as
mean  SD for continuous variables. Cox regression analysis
was used to identify the predominant predictors for late
aortic events of TBAD before surgical intervention. The
actuarial freedom from late aortic events and survivals were
computed using the KaplaneMeier method and compared
using the log-rank test. All statistical analyses were per-
formed using JMP 9.0 software (SAS Institute Inc., Cary, NC,
USA).
RESULTS
Of the 234 patients identiﬁed, 187 were male (mean age at
the time of surgery 60.4  13.0 years). A total of 132 pa-
tients had hypertension, while 32 had dyslipidemia (see
Table 1).
A total of 216 patients were treated electively for FL
aneurysm. Eighteen patients underwent emergency or ur-
gent operation. The indications for urgent operation were
rupture (n ¼ 7) or continuous pain (n ¼ 11). Fourteen
(6.0%) patients had a partially thrombosed FL, 37 (15.8%)
had a completely thrombosed FL, and 180 (76.9%) had a
patent FL. In the patent FL group, 10 patients had three-
channel aortic dissection. In three patients, the FL status
was unknown, because enhanced CT scans had not been
performed pre-operatively.
A total of 127 (54.3%) patients had descending thoracic
aortic enlargement, and 107 (45.7%) had thoraco-
abdominal aortic enlargement. The mean  SD maximum
AD was 58.4  10.7 mm. If the aneurysm had enlarged
>5 mm in 6 months, surgery was recommended, even if the
maximum diameter was <50 mm. The mean interval be-
tween onset of TBAD and operation was 61  54 months.
There were no signiﬁcant differences between FL patency
and interval between onset and surgical intervention
(Fig. 1).
The mean thickness of the FL was 37.3  14.3 mm. The
mean FL/AD ratio was 0.63  0.20. In 123 (52.5%) patients,
the FL/AD ratio was >0.7. There was no signiﬁcantFigure 1. (A) Interval between onset of type B aortic dissection and op
aortic dissection and operation of each group. p-Values were calculatecorrelation between the FL/AD ratio and the interval be-
tween TBAD onset and operation (r ¼ .1213). Cox regres-
sion analyses showed that neither the patent FL (p ¼ .50)
nor the FL/AD ratio (cut off  0.7; p ¼ .13) was a signiﬁcant
predictor of the interval between TBAD onset and
operation.
The operative details are shown in Table 2. DTAR was
performed in 127 (54.3%) patients, while TAAR was per-
formed in 107 (45.7%). In TAAR, the intercostal arteries
were reattached individually in 74 cases, the visceral vessels
were reattached in 84 cases, and beveled anastomosis was
performed in 14 cases. Additionally, fenestration at the
distal anastomosis site was performed in 138 (59.0%)
patients.
The overall operative and in hospital mortality rates were
6.8% (n ¼ 16) and 8.5% (n ¼ 20), respectively (Table 3). For
elective operations (n ¼ 216), the operative and in hospital
mortality rates were 4.6% and 6.0%, respectively. Major
adverse outcomes occurred in 41 (17.5%) patients. Of
these, permanent paraplegia occurred in ﬁve patients
(2.1%), and paraparesis occurred in nine (3.8%). Stroke
occurred in seven cases (3.0%), and a cardiac event in nine
(3.8%). Moreover, pulmonary complications occurred in 78
(33.3%) patients.eration of entire study group. (B) Interval between onset of type B
d using the log-rank test.
Table 3. Operative results.
Variable All
(n ¼ 234)
DTA
(n ¼ 127)
TAAA
(n ¼ 107)
p
Major adverse
outcome
41 (17.5) 14 (11.0) 27 (25.2) <.01
Overall operative
death
16 (6.8) 5 (3.9) 11 (10.3) .06
Elective (n ¼ 216) 16 (4.6) 2/119 (1.6) 8/97 (8.3) .02
In hospital death 20 (8.5) 8 (6.3) 12 (11.2) .18
Spinal cord deﬁcits 14 (6.0) 2 (1.6) 12 (11.2) <.01
Permanent
paraplegia
5 (2.1) 0 (0.0) 5 (4.7) .01
Paraparesis 9 (3.8) 2 (1.6) 7 (6.5) .05
Acute renal
dysfunction
24 (10.3) 8 (6.3) 20 (18.7) <.01
Dialysis at
discharge
9 (3.8) 1 (0.8) 8 (7.5) .01
Pulmonary
complication
78 (33.3) 37 (29.1) 41 (38.3) .14
Reoperation for
bleeding
9 (3.8) 3 (2.4) 6 (5.6) .20
Note. Data are n (%). DTA ¼ Descending thoracic aneurysm;
TAAA ¼ Thoraco-abdominal aortic aneurysm.
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overall elective operative mortality was 3.9% (5/127) in
DTAR and 1.7% (2/119) in DTAR. No paraplegia was
observed after DTAR for chronic TBAD. Paraparesis was
seen in 1.6% (2/127) of patients. For all TAAR operative
mortality and paraplegia were 10.2% (11/107) and 4.7% (5/
107). In elective TAAR, operative mortality and paraplegia
were 8.2% (8/97) and 4.1% (4/97), respectively. In non-
elective operations, operative mortality was 33.3% (6/18)
(DTAR, n ¼ 3; TAAR, n ¼ 3). The causes of operative death
were mesenteric ischemia (n ¼ 2), multiple organ failure
(n ¼ 1), multiple embolism (n ¼ 1), cerebral infarction
(n ¼ 1), and sudden death (n ¼ 1).
The 1 and 3 year post-operative survival rates were 87.6%
and 86.5%, respectively (Fig. 2). During the follow up
period, re-intervention for pseudoaneurysm at an anasto-
motic site or graft infection was necessary in seven (3.0%)
patients. In the follow up period, 24 (10.2%) patients
required additional aortic operations, including operations
unrelated to the primary dissection. Additional aorticFigure 2. (A) Cumulative survival of entire study group. (B) Cumulative
test. Note. p ¼ patent false lumen; t ¼ thrombosed or partially thromoperations, including aortic root replacement, total arch
replacement, TAAR, TEVAR, abdominal aortic replacement
(AAR), and endovascular aortic repair (EVAR) were per-
formed in two, seven, four, three, ﬁve, and seven patients,
respectively. Most cases of AAR and EVAR were intended
staged interventions following primary open surgery. In the
follow up period, four cases of type A dissection and one
case of remnant aneurysm rupture were considered as
aortic related deaths.DISCUSSION
Recently advancements in TEVAR technology have resulted
in expanded indications for TEVAR for TBAD.
For complicated TBAD accompanied by organ malperfu-
sion, TEVAR is generally performed, and has been reported
to achieve acceptable early outcomes. Alsac et al. per-
formed TEVAR for acute complicated TBAD and achieved
satisfactory early outcomes.7 Similarly, Patel et al. and Shah
et al. also reported on TEVAR for complicated TBAD8,9;
where the 30 day mortality rate was 17.4%, and mean
survival was 84.3 months. In addition they found that, while
the risk of late mortality was associated with age, no as-
sociation was observed for either the type or the number of
malperfused vessels.
For uncomplicated acute TBAD, medical treatment with
antihypertensive agents and rest has been shown to result
in acceptable in hospital outcomes. Accordingly, in their
systematic review, Fattori et al. reported a pooled early
mortality rate of 6.4% with medical treatment.6 However,
TEVAR for uncomplicated TBAD remains controversial. Shah
et al. found that TEVAR for acute uncomplicated TBAD was
associated with a similar in hospital mortality rate as
medical management,9 whereas De Rango and Estrera re-
ported that certain subgroups of patients with uncompli-
cated TBAD may beneﬁt from early stent graft placement,
although the identiﬁcation of these patients remains difﬁ-
cult.5 Nienaber et al. identiﬁed that aortic remodeling by
TEVAR for early-phase type B dissection lead to the
reduction of complications in the chronic phase.10 However,
in the present study, aortic expansion in the chronic phase
was observed independently of FL status. It is true that the
trial emphasizes the risk of rupture by the aortic expansionsurvival of each group. p-Values were calculated using the log-rank
bosed false lumen.
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essential even if patients undergo optimal medical treat-
ment. When the aortic diameter has expanded, elective
surgical intervention should be considered before a cata-
strophic event occurs. The basic strategy of the authors is
open surgery, and the operative results are acceptable,
especially in the elective setting. Open surgery for chronic
dissection has a low re-intervention rate.
In addition, the signiﬁcant predictors of late aortic events
after TBAD are currently unknown. Some investigators have
reported that a persistent FL may be a risk factor for
adverse outcomes11; however, others have argued that
aortic segments with a partially thrombosed FL are associ-
ated with a signiﬁcantly higher annual growth rate than
patients presenting with patent or complete thrombosis of
the FL.12
TEVAR is commonly performed for chronic TBAD in many
institutions, and has been demonstrated to be associated
with relatively low mortality and high re-intervention
rates.6,13 However, there are numerous reports suggesting
that open surgery is associated with a low re-intervention
rate.14 For these reasons, the basic strategy for uncompli-
cated TBAD at the authors’ institution is conservative
treatment in the acute phase and open surgery in the
chronic phase if the patient presents with aneurysmal
changes.
The objective of the present study was to retrospectively
examine the results of open surgery for chronic TBAD, and
the clinical features of the patients. The results revealed
that it took an average of 61  54 months (mean  SD;
median 43 months) until TBAD required surgical interven-
tion; a satisfactory event free survival was achieved in these
patients by medical treatment.
There was no signiﬁcant relationship between the FL/AD
ratio and the interval between onset of TBAD and surgery;
Cox regression analyses subsequently showed that neither a
patent FL nor an FL/AD ratio 0.7 was correlated with the
time between onset of TBAD and operation.
Lastly, the operative outcomes for chronic TBAD showed
satisfactory in hospital mortality and 1 and 3 year survival
rates. Thus, considering the low re-intervention rate of open
surgery, the strategy presented here for chronic aortic
dissection is useful.
The present study had several limitations. First, the study
was retrospective and limited to patients who underwent
open surgery at the authors’ institution. Several other pa-
rameters have been suggested as markers of late aneu-
rysmal formation after TBAD including entry tear size and
location, and extent of the dissection. These parameters
could not be analyzed. The authors seldom consider TEVAR
for chronic dissectiondthe basic strategy is open surgery. In
this study, TEVAR for chronic dissection was performed in
only two cases, and open surgery only rarely considered
entry tear size and location of dissection.
Second, only 187 (79.9%) patients had information
regarding the onset date of TBAD. Hence, predictors of late
aortic events may have been identiﬁed if complete data
regarding the onset date had been available. Third, this wasa single center study with a limited number of patients, and
no ﬁrm conclusions can therefore be drawn from the
ﬁndings.
In conclusion, enlargement of uncomplicated TBAD in the
chronic phase does not appear to be related to the
thrombosis and diameter of FL, and open repair is associ-
ated with acceptable early outcomes and a low re-
intervention rate, as well as fewer morphologic limita-
tions. While these results should be considered in the
treatment of TBAD, further prospective large scale studies
are needed to conﬁrm the ﬁndings.
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